EC
EXAS

EntryPoint Capital’s Exact Sciences EXAS Stock Holding History

EntryPoint Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,825
Closed -$533K – 804
2024
Q3 		$533K Buy
+7,825
New +$442K 0.3% 34
2024
Q2 		– Sell
-977
Closed -$67.5K – 1109
2024
Q1 		$67.5K Buy
+977
New +$61.8K 0.06% 612

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EntryPoint Capital's EXAS Position: Q4 2024 in Review

EntryPoint Capital sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 7,825 shares — an estimated $533K sold.

EntryPoint Capital first reported a position in EXAS in Q1 2024 and held it in 2 quarters. The position peaked at $533K in Q3 2024. 592 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • EntryPoint Capital reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • EntryPoint Capital sold 7,825 Exact Sciences shares in Q4 2024, an estimated $533K.
  • EntryPoint Capital first reported a position in Exact Sciences in Q1 2024 and held it in 2 quarters.
  • EntryPoint Capital's Exact Sciences position peaked at $533K in Q3 2024.
  • 592 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.